Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening
暂无分享,去创建一个
H. Moser | A. Moser | G. Raymond | P. Watkins | P. Rinaldo | N. Kass | Lena Bezman | Ann B. Moser | Gerald V. Raymond | Piero Rinaldo | Paul A. Watkins | Kirby D. Smith | Nancy E. Kass | Hugo W. Moser | Kirby D. Smith | L. Bezman | H. Moser | Nancy E. Kass | Nancy E. Kass
[1] H. Moser,et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.
[2] H. Moser,et al. X-Linked Adrenoleukodystrophy: Overview and Prognosis as a Function of Age and Brain Magnetic Resonance Imaging Abnormality. A Study Involving 372 Patients , 2000, Neuropediatrics.
[3] J. Mandel,et al. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. , 1996, American journal of human genetics.
[4] D. Schaid. Mathematical and Statistical Methods for Genetic Analysis , 1999 .
[5] B. Haldane. MUTATION IN THE SEX‐LINKED RECESSIVE TYPE OF MUSCULAR DYSTROPHY. A POSSIBLE SEX DIFFERENCE , 1956, Annals of human genetics.
[6] H. Moser,et al. Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. , 1999, Molecular genetics and metabolism.
[7] H. J. Brink,et al. Stable isotope dilution analysis of very long chain fatty acids in plasma, urine and amniotic fluid by electron capture negative ion mass fragmentography. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[8] A. Fischer,et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. , 1990, The New England journal of medicine.
[9] H. Moser,et al. Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy , 2001, Annals of neurology.
[10] H. Moser,et al. Altered expression of ALDP in X-linked adrenoleukodystrophy. , 1995, American journal of human genetics.
[11] P. Aubourg,et al. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder , 1999, Trends in Neurosciences.
[12] E. Bertini,et al. Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement. , 1997, Brain : a journal of neurology.
[13] M A Hall,et al. Laws restricting health insurers' use of genetic information: impact on genetic discrimination. , 2000, American journal of human genetics.
[14] I. Jambaqué,et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy , 2000, The Lancet.
[15] J. Mosser,et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. , 1994, Human molecular genetics.
[16] Bartha Maria Knop. ASHG statement. Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. , 1998, American journal of human genetics.
[17] R. Abramson,et al. Attitudes toward presymptomatic testing and prenatal diagnosis for adrenoleukodystrophy among affected families. , 1991, American journal of medical genetics.
[18] H. Moser,et al. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. , 1997, Brain : a journal of neurology.
[19] H. Moser,et al. Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. , 1998, American journal of medical genetics.